Preferences of patients and clinicians for treatment of Graves' disease: a discrete choice experiment.
Caroline M J van KinschotVikas R SoekhaiEsther W de Bekker-GrobW Edward VisserRobin P PeetersTessa M van GinhovenCharlotte van NoordPublished in: European journal of endocrinology (2021)
For both patients and clinicians, remission rate was the most important determinant of treatment choice and ATD was the most preferred treatment option. Patients had a negative preference toward RAI compared to alternatives, whereas clinicians preferred RAI over surgery. Clinicians should be aware that their personal attitude toward RAI differs from that of their patients. This study on patients' and clinicians' preferences can support shared decision making and thereby improve clinical treatment.